O	O	0	15	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD	O
O	O	16	26	regulation	regulation	I-NP	NN	O	0	ROOT	O
O	O	27	29	of	of	B-PP	IN	O	2	NMOD	O
O	O	30	33	the	the	B-NP	DT	O	8	NMOD	O
T1	B-Protein	34	45	interleukin	interleukin	I-NP	NN	B-DNA	8	NMOD	B-DNA
T1	I-Protein	45	46	-	-	B-NP	HYPH	I-DNA	8	NMOD	I-DNA
T1	I-Protein	46	47	2	2	I-NP	CD	I-DNA	8	NMOD	I-DNA
O	O	48	52	gene	gene	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	53	55	in	in	B-PP	IN	O	2	NMOD	O
O	O	56	62	normal	normal	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	63	68	human	human	I-NP	JJ	I-cell_type	15	NMOD	I-cell_type
O	O	69	79	peripheral	peripheral	I-NP	JJ	I-cell_type	15	NMOD	I-cell_type
O	O	80	85	blood	blood	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	86	87	T	T	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	88	93	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	93	94	.	.	O	.	O	2	P	O

O	O	95	106	Convergence	Convergence	B-NP	NN	O	6	NMOD	O
O	O	107	109	of	of	B-PP	IN	O	1	NMOD	O
O	O	110	123	costimulatory	costimulatory	B-NP	JJ	O	4	NMOD	O
O	O	124	131	signals	signal	I-NP	NNS	O	2	PMOD	O
O	O	132	135	and	and	I-NP	CC	O	6	NMOD	O
O	O	136	147	differences	difference	I-NP	NNS	O	0	ROOT	O
O	O	148	152	from	from	B-PP	IN	O	6	NMOD	O
O	O	153	164	transformed	transform	B-NP	VBN	B-cell_type	10	NMOD	B-cell_type
O	O	165	166	T	T	I-NP	NN	I-cell_type	10	NMOD	I-cell_type
O	O	167	172	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	172	173	.	.	O	.	O	6	P	O

O	O	175	177	To	To	B-VP	TO	O	2	VMOD	O
O	O	178	183	study	study	I-VP	VB	O	12	VMOD	O
O	O	184	199	transcriptional	transcriptional	B-NP	JJ	O	4	NMOD	O
O	O	200	210	regulation	regulation	I-NP	NN	O	2	OBJ	O
O	O	211	213	in	in	B-PP	IN	O	4	NMOD	O
O	O	214	220	normal	normal	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	221	226	human	human	I-NP	JJ	I-cell_type	9	NMOD	I-cell_type
O	O	227	228	T	T	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	229	234	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	234	235	,	,	O	,	O	12	P	O
O	O	236	238	we	we	B-NP	PRP	O	12	SUB	O
O	O	239	243	have	have	B-VP	VBP	O	0	ROOT	O
O	O	244	253	optimized	optimize	I-VP	VBN	O	12	VC	O
O	O	254	264	conditions	condition	B-NP	NNS	O	13	OBJ	O
O	O	265	268	for	for	B-PP	IN	O	14	NMOD	O
O	O	269	278	transient	transient	B-NP	JJ	O	17	NMOD	O
O	O	279	291	transfection	transfection	I-NP	NN	O	15	PMOD	O
O	O	291	292	.	.	O	.	O	12	P	O

T2	B-Protein	293	304	Interleukin	Interleukin	B-NP	NN	B-DNA	13	NMOD	B-DNA
T2	I-Protein	304	305	-	-	O	HYPH	I-DNA	1	P	I-DNA
T2	I-Protein	305	306	2	2	B-NP	CD	I-DNA	1	NMOD	I-DNA
O	O	307	308	(	(	O	(	I-DNA	13	NMOD	I-DNA
T3	B-Protein	308	310	IL	IL	B-NP	NN	I-DNA	13	NMOD	I-DNA
T3	I-Protein	310	311	-	-	O	HYPH	I-DNA	7	P	I-DNA
T3	I-Protein	311	312	2	2	O	CD	I-DNA	13	NMOD	I-DNA
O	O	312	313	)	)	O	)	I-DNA	13	NMOD	I-DNA
T8	B-Entity	314	322	promoter	promoter	B-NP	NN	I-DNA	13	NMOD	I-DNA
T9	I-Entity	322	323	-	-	B-NP	HYPH	O	13	NMOD	O
T9	I-Entity	323	331	reporter	reporter	I-NP	NN	B-DNA	12	NMOD	B-DNA
T9	I-Entity	332	336	gene	gene	I-NP	NN	I-DNA	13	NMOD	I-DNA
O	O	337	345	behavior	behavior	I-NP	NN	O	15	SUB	O
O	O	346	353	closely	closely	B-ADVP	RB	O	15	VMOD	O
O	O	354	363	parallels	parallel	B-VP	VBZ	O	0	ROOT	O
O	O	364	367	the	the	B-NP	DT	O	18	NMOD	O
T10	B-Entity	368	378	endogenous	endogenous	I-NP	JJ	B-DNA	18	NMOD	B-DNA
T10	I-Entity	379	383	gene	gene	I-NP	NN	I-DNA	15	OBJ	I-DNA
O	O	384	386	in	in	B-PP	IN	O	15	VMOD	O
O	O	387	395	response	response	I-PP	NN	O	19	PMOD	O
O	O	396	398	to	to	I-PP	TO	O	20	NMOD	O
O	O	399	400	T	T	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	401	405	cell	cell	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	406	414	receptor	receptor	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	415	418	and	and	O	CC	O	27	NMOD	O
O	O	419	432	costimulatory	costimulatory	B-NP	JJ	O	27	NMOD	O
O	O	433	440	signals	signal	I-NP	NNS	O	21	PMOD	O
O	O	440	441	.	.	O	.	O	15	P	O

O	O	442	444	As	As	B-SBAR	IN	O	21	VMOD	O
O	O	445	453	assessed	assess	B-VP	VBN	O	1	SBAR	O
O	O	454	458	with	with	B-PP	IN	O	2	VMOD	O
T11	B-Entity	459	470	mutagenized	mutagenize	B-NP	VBN	B-DNA	5	NMOD	B-DNA
T11	I-Entity	471	480	promoters	promoter	I-NP	NNS	I-DNA	3	PMOD	I-DNA
O	O	480	481	,	,	O	,	O	21	P	O
O	O	482	485	the	the	B-NP	DT	O	16	NMOD	O
O	O	486	490	most	most	I-NP	RBS	O	9	AMOD	O
O	O	491	500	important	important	I-NP	JJ	O	16	NMOD	O
T4	B-Protein	501	503	IL	IL	I-NP	NN	B-DNA	16	NMOD	B-DNA
T4	I-Protein	503	504	-	-	O	HYPH	I-DNA	16	NMOD	I-DNA
T4	I-Protein	504	505	2	2	B-NP	CD	I-DNA	16	NMOD	I-DNA
T12	B-Entity	506	509	cis	cis	I-NP	NN	I-DNA	16	NMOD	I-DNA
T12	I-Entity	509	510	-	-	B-NP	HYPH	I-DNA	16	NMOD	I-DNA
T12	I-Entity	510	520	regulatory	regulatory	I-NP	JJ	I-DNA	16	NMOD	I-DNA
T12	I-Entity	521	529	elements	element	I-NP	NNS	I-DNA	21	SUB	I-DNA
O	O	530	532	in	in	B-PP	IN	O	16	NMOD	O
O	O	533	539	normal	normal	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	540	541	T	T	I-NP	NN	I-cell_type	20	NMOD	I-cell_type
O	O	542	547	cells	cell	I-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	548	551	are	be	B-VP	VBP	O	0	ROOT	O
O	O	552	555	the	the	B-NP	DT	O	27	NMOD	O
T13	B-Entity	556	564	proximal	proximal	I-NP	JJ	B-DNA	27	NMOD	B-DNA
T13,T14	I-Entity,B-Entity	565	567	AP	AP	I-NP	NN	I-DNA	27	NMOD	I-DNA
T13,T14	I-Entity,I-Entity	567	568	-	-	B-NP	HYPH	I-DNA	27	NMOD	I-DNA
T13,T14	I-Entity,I-Entity	568	569	1	1	I-NP	CD	I-DNA	27	NMOD	I-DNA
T13	I-Entity	570	574	site	site	I-NP	NN	I-DNA	33	NMOD	I-DNA
O	O	575	578	and	and	O	CC	O	33	NMOD	O
O	O	579	582	the	the	B-NP	DT	O	33	NMOD	O
T15,T16	B-Entity,B-Entity	583	585	NF	NF	I-NP	NN	B-DNA	33	NMOD	B-DNA
T15,T16	I-Entity,I-Entity	585	586	-	-	B-NP	HYPH	I-DNA	33	NMOD	I-DNA
T15,T16	I-Entity,I-Entity	587	593	kappaB	kappaB	I-NP	NN	I-DNA	33	NMOD	I-DNA
T15	I-Entity	594	598	site	site	I-NP	NN	I-DNA	21	PRD	I-DNA
O	O	598	599	.	.	O	.	O	21	P	O

O	O	600	604	Both	Both	O	CC	O	13	NMOD	O
O	O	605	612	primary	primary	B-NP	JJ	O	3	NMOD	O
O	O	613	623	activation	activation	I-NP	NN	O	13	NMOD	O
O	O	623	624	,	,	O	,	O	3	P	O
O	O	625	629	with	with	B-PP	IN	O	3	NMOD	O
T5	B-Protein	630	648	phytohemagglutinin	phytohemagglutinin	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	649	651	or	or	I-NP	CC	O	8	NMOD	O
O	O	652	662	antibodies	antibody	I-NP	NNS	O	5	PMOD	O
O	O	663	665	to	to	B-PP	TO	O	8	NMOD	O
T17	B-Entity	666	669	CD3	CD3	B-NP	NN	B-protein	9	PMOD	B-protein
O	O	669	670	,	,	O	,	O	13	P	O
O	O	671	674	and	and	O	CC	O	13	NMOD	O
O	O	675	688	costimulation	costimulation	B-NP	NN	O	39	SUB	O
O	O	688	689	,	,	O	,	O	13	P	O
O	O	690	698	provided	provide	B-PP	VBN	O	13	NMOD	O
O	O	699	701	by	by	B-PP	IN	O	15	VMOD	O
O	O	702	707	pairs	pair	B-NP	NNS	O	37	NMOD	O
O	O	708	710	of	of	B-PP	IN	O	17	NMOD	O
O	O	711	714	CD2	CD2	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	715	725	antibodies	antibody	I-NP	NNS	I-protein	18	PMOD	I-protein
O	O	726	728	or	or	O	CC	O	37	NMOD	O
O	O	729	731	B7	B7	B-ADJP	NN	B-protein	37	NMOD	B-protein
O	O	731	732	-	-	I-ADJP	HYPH	O	37	P	O
O	O	732	740	positive	positive	I-ADJP	JJ	O	37	NMOD	O
O	O	741	742	(	(	O	(	O	28	DEP	O
O	O	742	743	B	B	B-NP	NN	B-cell_type	27	NMOD	B-cell_type
O	O	744	749	cells	cell	I-NP	NNS	I-cell_type	28	DEP	I-cell_type
O	O	749	750	)	)	O	)	O	24	AMOD	O
O	O	751	753	or	or	O	CC	O	37	NMOD	O
O	O	754	756	B7	B7	B-NP	NN	B-protein	37	NMOD	B-protein
O	O	756	757	-	-	O	HYPH	O	37	P	O
O	O	757	765	negative	negative	O	JJ	O	37	NMOD	O
O	O	766	767	(	(	O	(	O	37	NMOD	O
O	O	767	778	endothelial	endothelial	B-ADJP	JJ	O	37	NMOD	O
O	O	778	779	)	)	O	)	O	37	NMOD	O
O	O	780	789	accessory	accessory	B-NP	JJ	O	37	NMOD	O
O	O	790	795	cells	cell	I-NP	NNS	O	16	PMOD	O
O	O	795	796	,	,	O	,	O	13	P	O
O	O	797	800	are	be	B-VP	VBP	O	0	ROOT	O
O	O	801	809	mediated	mediate	I-VP	VBN	O	39	VC	O
O	O	810	817	through	through	B-PP	IN	O	40	VMOD	O
O	O	818	821	the	the	B-NP	DT	O	43	NMOD	O
O	O	822	826	same	same	I-NP	JJ	O	41	PMOD	O
T18	B-Entity	827	830	cis	cis	I-NP	NN	B-DNA	46	NMOD	B-DNA
T18	I-Entity	830	831	-	-	B-NP	HYPH	I-DNA	46	NMOD	I-DNA
T18	I-Entity	831	839	elements	element	I-NP	NNS	I-DNA	43	NMOD	I-DNA
O	O	839	840	.	.	O	.	O	39	P	O

O	O	841	854	Interestingly	Interestingly	B-ADVP	RB	O	11	VMOD	O
O	O	854	855	,	,	O	,	O	11	P	O
O	O	856	859	the	the	B-NP	DT	O	10	NMOD	O
T19	B-Entity	860	867	nuclear	nuclear	I-NP	JJ	B-DNA	10	NMOD	B-DNA
T19	I-Entity	868	874	factor	factor	I-NP	NN	I-DNA	10	NMOD	I-DNA
T19	I-Entity	875	877	of	of	B-PP	IN	I-DNA	10	NMOD	I-DNA
T19	I-Entity	878	887	activated	activate	B-NP	VBN	I-DNA	10	NMOD	I-DNA
T19	I-Entity	888	889	T	T	I-NP	NN	I-DNA	10	NMOD	I-DNA
T19	I-Entity	890	894	cell	cell	I-NP	NN	I-DNA	10	NMOD	I-DNA
T19	I-Entity	895	900	sites	site	I-NP	NNS	I-DNA	11	SUB	I-DNA
O	O	901	904	are	be	B-VP	VBP	O	0	ROOT	O
O	O	905	909	much	much	B-ADJP	RB	O	11	PRD	O
O	O	910	914	less	less	I-ADJP	RBR	O	12	AMOD	O
O	O	915	924	important	important	I-ADJP	JJ	O	12	AMOD	O
O	O	925	927	in	in	B-PP	IN	O	12	AMOD	O
O	O	928	934	normal	normal	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	935	936	T	T	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	937	942	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	943	947	than	than	B-PP	IN	O	12	AMOD	O
O	O	948	950	in	in	B-PP	IN	O	19	PMOD	O
O	O	951	957	Jurkat	Jurkat	B-NP	NN	B-cell_line	23	NMOD	B-cell_line
O	O	958	959	T	T	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	960	965	cells	cell	I-NP	NNS	I-cell_line	20	PMOD	I-cell_line
O	O	965	966	.	.	O	.	O	11	P	O

O	O	967	969	We	We	B-NP	PRP	O	2	SUB	O
O	O	970	978	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	979	983	that	that	B-SBAR	IN	O	20	DEP	O
T6	B-Protein	984	986	IL	IL	B-NP	NN	B-protein	8	NMOD	B-protein
T6	I-Protein	986	987	-	-	B-NP	HYPH	I-protein	4	NMOD	I-protein
T6	I-Protein	987	988	2	2	I-NP	CD	I-protein	4	NMOD	I-protein
O	O	989	1004	transcriptional	transcriptional	I-NP	JJ	O	8	NMOD	O
O	O	1005	1015	regulation	regulation	I-NP	NN	O	9	SUB	O
O	O	1016	1023	differs	differ	B-VP	VBZ	O	3	SBAR	O
O	O	1024	1026	in	in	B-PP	IN	O	9	VMOD	O
O	O	1027	1032	tumor	tumor	B-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	1033	1037	cell	cell	I-NP	NN	I-cell_line	13	NMOD	I-cell_line
O	O	1038	1043	lines	line	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	1044	1052	compared	compare	B-PP	VBN	O	9	VMOD	O
O	O	1053	1057	with	with	B-PP	IN	O	14	PMOD	O
O	O	1058	1064	normal	normal	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	1065	1066	T	T	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	1067	1072	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	1073	1076	and	and	O	CC	O	20	DEP	O
O	O	1077	1081	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	1082	1091	different	different	B-NP	JJ	O	23	NMOD	O
O	O	1092	1105	costimulatory	costimulatory	I-NP	JJ	O	23	NMOD	O
O	O	1106	1113	signals	signal	I-NP	NNS	O	24	SUB	O
O	O	1114	1122	converge	converge	B-VP	VBP	O	20	SBAR	O
O	O	1123	1125	on	on	B-PP	IN	O	24	VMOD	O
O	O	1126	1129	the	the	B-NP	DT	O	30	NMOD	O
O	O	1130	1134	same	same	I-NP	JJ	O	30	NMOD	O
T20	B-Entity	1135	1138	cis	cis	I-NP	NN	B-DNA	30	NMOD	B-DNA
T20	I-Entity	1138	1139	-	-	B-NP	HYPH	I-DNA	30	NMOD	I-DNA
T20	I-Entity	1139	1147	elements	element	I-NP	NNS	I-DNA	25	PMOD	I-DNA
O	O	1148	1150	in	in	B-PP	IN	O	30	NMOD	O
O	O	1151	1154	the	the	B-NP	DT	O	36	NMOD	O
T7	B-Protein	1155	1157	IL	IL	I-NP	NN	B-DNA	36	NMOD	B-DNA
T7	I-Protein	1157	1158	-	-	I-NP	HYPH	I-DNA	36	NMOD	I-DNA
T7	I-Protein	1158	1159	2	2	I-NP	CD	I-DNA	36	NMOD	I-DNA
T21	B-Entity	1160	1168	promoter	promoter	I-NP	NN	I-DNA	31	PMOD	I-DNA
O	O	1168	1169	.	.	O	.	O	2	P	O
